about
Use of green fluorescent protein-expressing Aspergillus fumigatus conidia to validate quantitative PCR analysis of air samples collected on filtersPathogenesis of Aspergillus fumigatus in Invasive AspergillosisGuidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspectiveNew inhalation-optimized itraconazole nanoparticle-based dry powders for the treatment of invasive pulmonary aspergillosisDisruption of the Aspergillus fumigatus gene encoding nucleolar protein CgrA impairs thermotolerant growth and reduces virulence.Consensus guidelines for implementation of quality processes to prevent invasive fungal disease and enhanced surveillance measures during hospital building works, 2014.Hospital environment fungal contamination and aspergillosis risk in acute leukaemia patients in Sousse (Tunisia).Successful pneumonectomy for invasive pulmonary aspergillosis and advanced non-small cell-lung cancer.Ecophysiology of environmental Aspergillus fumigatus and comparison with clinical strains on gliotoxin production and elastase activity.In vitro activity of disinfectants against Aspergillus spp.Evolution of the environmental contamination by thermophilic fungi in a turkey confinement house in France.Outbreak of invasive aspergillosis after major heart surgery caused by spores in the air of the intensive care unit.Filamentous fungi in a tertiary care hospital: environmental surveillance and susceptibility to antifungal drugs.[Invasive fungal infections in patients after liver transplantation]Fungal contamination in hospital environments.Usefulness of Aspergillus Galactomannan Antigen Testing and the Prediction of an Outbreak during Hospital Reconstruction.Pollen and spore monitoring in the world.Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation.Recent Developments in Inhaled Triazoles Against Invasive Pulmonary AspergillosisNew Respirable and Fast Dissolving Itraconazole Dry Powder Composition for the Treatment of Invasive Pulmonary Aspergillosis
P2860
Q23914281-C09DF006-9868-4C0E-9FB8-49034D28A6B8Q24650911-58EDE11F-4AB6-4B02-A278-B0930765BD18Q28388806-FDC4A91F-B186-4C90-858F-880D076752EDQ34456015-350D83D4-CB5D-4A23-8AB0-AF3D7693FF18Q36443838-F942F7EB-3113-46F4-B009-8A7012C5189FQ38284470-4731A6A5-3EDB-45AC-B668-B0B52EEF17BAQ39022118-24A548D1-7E5B-4FF9-8797-567DD6714C30Q39653392-76F21EC1-DED8-442F-8280-80FB3B1977E4Q40917293-22EF2ECF-898D-4B32-B47B-C300F09A4701Q41891828-5647CEBA-C1A7-4A46-A0A9-8C34ADF56372Q43021311-6C9D889D-D14E-445F-AC07-BBA94AC4E460Q44010583-CBB5BFD1-2EC3-4BD8-B010-BE432F502E4BQ46362922-87DBAE87-E410-4752-BF81-FEDBC592562EQ46434488-F422E50A-B347-48D1-A29C-82F1ECE40E7BQ51286315-8261D22C-395F-402C-87DC-F2DF9AFA1EF2Q51783998-8D21F9F8-58DE-4216-B1EA-03E2E75C3C53Q52595096-4A8F4C4A-683D-491F-A8C4-119ACFEA6EADQ54240772-2C1F4AB8-1919-4360-B172-2AE614C40315Q59089511-601FF709-36CF-4E72-A1B9-72D96C75000BQ59089617-6A92F103-0C74-4E59-81FC-D7B914D40E50
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Sampling of Aspergillus spores in air.
@ast
Sampling of Aspergillus spores in air.
@en
type
label
Sampling of Aspergillus spores in air.
@ast
Sampling of Aspergillus spores in air.
@en
prefLabel
Sampling of Aspergillus spores in air.
@ast
Sampling of Aspergillus spores in air.
@en
P2093
P356
P1476
Sampling of Aspergillus spores in air.
@en
P2093
Anderson K
Richardson MD
P356
10.1053/JHIN.1999.0688
P577
2000-02-01T00:00:00Z